Analyst Ratings For Intec Pharma (NASDAQ:NTEC) (NASDAQ:NTEC)
Today, Maxim Group raised its price target on Intec Pharma (NASDAQ:NTEC) (NASDAQ:NTEC) to $12.00 per share.
Some recent analyst ratings include
- 3/21/2018-Oppenheimer Reiterated Rating of Buy.
- 2/28/2018-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
- 9/21/2017-CIBC Reiterated Rating of Outperform .
Recent Trading Activity for Intec Pharma (NASDAQ:NTEC) (NASDAQ:NTEC)
Shares of Intec Pharma (NASDAQ:NTEC) closed the previous trading session at 6.23 down -0.12 1.97% with 6.349999904632568 shares trading hands.